Not Yet Recruiting
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
NCT07301424
- Conditions
- Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
- Locations
-
- University of Alberta Edmonton, Alberta, Canada